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Summary: fi-Mannosidase deficiency was demonstrated in fibroblasts of a girl 
who showed severe psychomotor retardation, bone deformities and gargoylism 
and recurrent skin and respiratory infections and who died at 20 years of age 
from bronchopneumonia. This first demonstration f a female patient confirms 
the autosomal recessive inheritance of fi-mannosidosis. Further investigation of
this gipsy family revealed fl-mannosidosis in an older brother with a milder 
manifestation of gargoyl facial dysmorphology, mental retardation, hearing 
impairment and recurrent infections, fi-Mannosidase activity was completely 
deficient in his cultured skin fibroblasts, leukocytes and plasma. In urine a 
characteristic disaccharide was present. Heterozygote l vels of fl-mannosidase 
were found in fibroblasts and/or plasma of the parents and one sister. 
/~-Mannosidosis (McKusick 24851) is a lysosomal storage disease caused by the 
deficiency of/~-mannosidase (EC 3.2.1.25). The disorder was first described in goats 
as a severe and rapidly fatal neurological disease (Jones and Dawson, t981; Lovell 
and Jones, 1983). The human counterpart was reported simultaneously by Cooper 
and colleagues (1986) in two adult brothers and by Wenger and colleagues (1986) in 
a 4-year-old boy. Subsequently, Dorland and colleagues (1988) described two brothers 
of 7 and 9 years of age with elevated urinary levels of the disaccharide mannosyl- 
fl(1 --, 4)-N-acetylglucosamine a d fl-mannosidase d ficiency. 
The patients described thus far are all mentally retarded but further manifestations 
are heterogeneous and much milder than in the caprine disease. Since the report of 
fi-mannosidosis n goats; several groups have searched for the human disease by 
screening patients with neurological and presumably sosomal disease. We did not 
detect his enzyme deficiency in a series of 40 stored celt lines from young patients 
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with progressive neurological deterioration (Panday et al., 1984). More recently we 
studied another series of cell lines from older patients or those with generally milder 
symptoms and demonstrated/~-mannosidosis in a girl who was 13 years of age at 
the time of skin biopsy. This first female patient and her older affected brother are 
reported in this paper. 
PATIENTS AND METHODS 
Clinical: The proband (1I-8; Figure 1) was one of dizygous twins in a sibship of 
nine children. The gipsy parents originate from two small neighbouring villages in 
Czechoslovakia but consanguinity was not proven. One child (I1-3) died from 
respiratory disease at six months of age. All the other children are mentally retarded 
to various degrees. In three of them the retardation is mild and no other abnormalities 
are reported (11-4,5 and 9). Five children have grown up in institutions for oligophrenic 
children (I1-1,2,6,7 and 8), one of whom could not be traced (II-1). Clinical data for 
the other four children are summarized below. 
11-8: The female proband was born in 1966 and died in 1986 from bronchopneu- 
monia and sepsis. Psychomotor retardation was apparent from early life. The girl 
could crawl only at 14 months of age, could sit only at 18 months, was very hypotonic, 
and was severely mentally retarded. From the fourth year onwards there are 
reports of recurrent skin and respiratory infections, severe anaemia, epistaxis and 
automutilation such as the tearing of hairs leading to local alopecia. Further features 
were gargoyl facies, hypertelorism, macroglossia, gingival hyperplasia, short neck, 
umbilical hernia and skeletal abnormalities (deformities of the thorax, lumbar 
hyperlordosis and nanism: height 1.10m at 18 years of age; weight 22kg) and 
increased fragility of capillaries. There was no hepatosplenomegaly. 
The EEG showed a tack of basal activity. Haematological examination showed 
slight vacuolization and granulation of bone marrow cells. X-ray examination showed 
broad ribs, pelvic asymmetry, spina bifida occulta and severe scoliosis. 
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Figure 1 Pedigree of the family with fl-mannosidosis./~-Mannosidase activity is deficient in 
II-2 and 8, reduced in the parents and 11-7 and normal in I1-9. Siblings I1-1,3,4,5 and 6 were 
not available for study. 
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11-2: This older brother is moderately mentally retarded and shows occasional 
aggressive behaviour. Hearing is impaired; facial features are coarse with slight 
hypertelorism and thick lips but are not so clearly gargoyl-like as in proband II-8. 
Slight scoliosis was observed by X-ray examination. There are frequently recurring 
erysipelas-like skin changes and respiratory infections. His height is normal: 1.83 m 
at 30 years of age. 
11-6: This sister was born in 1964 and died in 1980 with severe dystrophy and 
terminal bronchopneumonia. Shehad microcephaly with low frontal port of the skull 
and was severely mentally retarded; she could sit only at six years of age. Muscular 
hypotony and scoliosis were r ported as well as coarse facies with a broad mouth, 
but not gargoyMike as in proband II-8. 
11-7: This twin sister is also severely mentally retarded with dyslalia due to perinatal 
encephalopathy. From her fourth year she suffered from paroxysmal epilepsy. There 
is no facial dysmorphology as in proband II-8. 
Biochemical studies: Fibroblasts were cultured from a skin biopsy of proband II-8 
in 1979 and have been stored in the cell bank. No other material was available for 
recent studies as the patient died in 1986. Blood and/or skin biopsies have been 
collected from the parents 0-1 and 2) and from the siblings II-2,7 and 9. Urine was 
collected from sibling II-2. No material could be obtained from the other siblings, 
because they either could not be traced (II-1,4 and 5) or had died (II-3,6). 
fl-Mannosidase activity was assayed as described previously (Panday et al., 1984). 
Other lysosomal enzyme activities and [3sS]-sulphate incorporation levels were 
measured according to the method of Galjaard (1980). Thin layer chromatography 
of oligosaccharides was performed on silica coated plates using solvent 1 as described 
by Blom and colleagues (1983) (n-butanol-acetic a id-water, 2:1:1 by volume) or 
solvent 2 as described by Dorland and colleagues (1988) (n-propanol-acetic a id- 
water, 85:1:15 by volume). The TLC plate was developed twice in the same solvent. 
RESULTS 
Enzyme studies: The clinical features of proband II-8 suggested a lysosomat s orage 
disease, perhaps mucolipidosis type II or III. Skin fibrobtasts were cultured and 
investigated for several lysosomal enzyme activities. Normal activities were established 
for fl-galactosidase, ~-mannosidase, c~-fucosidase, c~-glucosidase nd e-N-acetylneur- 
aminidase (values not shown), which excluded mucolipidosis II and III and the 
isolated enzyme deficiencies as well. As a general test for most known types of 
mucopolysaccharidoses, [35S]-sulphate incorporation in glycosaminoglycans was 
determined and found to be normal. Finally, fl-mannosidase activity in the patient's 
fibroblasts was shown to be completely deficient (Table 1). By the time this fi- 
mannosidase d ficiency was found, the patient had died and urine, blood or tissues 
were not available for further studies. Three of the patient's siblings and her parents 
could be traced and were prepared to donate a skin biopsy, blood or urine. 
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Table 1 
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/LMannosidase activity in cultured fibroblasts, leukoeytes and 
Fibroblastsa Leukocytes ~ Plasma b
Patient, II-8 c 0.0 - - 
Patient, II-2 0.6 0.9 0.1 
Sister, II-7 29 59 54 
Sister, II-9 - - 90 
Father, I-1 45 - 79 
Mother, I-2 28 - 67 
Controls, mean -+-SD 91 ± 30 85 ± 15 138 _+ 20 
Range 51-195 45-150 87-188 
n 76 42 48 
"nmol/h per mg protein; bnmol/h per ml; ~The pedigree is shown in Figure 1 
/~-Mannosidase appeared to be deficient in fibroblasts, leukocytes and plasma from 
the brother (II-2), whereas reference lysosomal enzymes were normal. Fibroblasts 
and plasma of the twin sister (II-7) and the parents had a reduced enzyme activity 
suggesting heterozygosity. Of the youngest sister (II-9) only plasma could be stndied; 
/%mannosidase was normal (Table 1). 
Heparan sulphate sulphamidase activity was normal in fibroblasts of both patients 
with/~-mannosidase deficiency (data not shown). 
Urine analysis: Urine from patient II-2, sister II-9 and their parents was analysed 
for oligosaccharides. Figure 2 shows an abnormal band in the oligosaccharide pattern 
on TLC of the urine of patient II-2. The abnormal oligosaccharide coincides with 
lactose if solvent 1 is used, whereas it is separated from lactose in solvent 2. The 
patterns for sister II-9 and the parents were normal. 
DISCUSSION 
/~-Mannosidase d ficiency in two siblings from a large gipsy family, described in this 
paper, was associated with mental retardation, hearing impairment, recurrent 
infections of the skin and respiratory tract and gargoyl-like facial dysmorphism. The 
female proband (II-8, Figure 1) was severely affected in these and several other 
respects which became fatal at 20 years of age, whereas the brother is not so severely 
affected. 
It is difficult to identify a consistent pattern of clinical manifestations among the 
seven patients in the four families described until now, including the present cases. 
Various degrees of mental retardation and hearing loss with associated impairment 
of speech are common findings. Aggressive behaviour was mentioned in one of the 
adult patients described by Cooper and colleagues (1990) and in our adult patient 
(II-2). Isolated observations are angiokeratoma in the brothers described by Cooper 
and colleagues (1986, 1988). Our two patients had recurrent infections of the skin 
(erysipelas) and respiratory tract; respiratory infections were also observed in the 
patients described by Dorland and colleagues (1988). Coarse facies and skeletal 
abnormalities were present in our two patients and in the patient described by 
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Figure 2 Thin layer chromatography of urinary oligosaccharides from fl-mannosidosis patient 
II-2 and his healthy sister II-9 and parents I-1and 2. The extra band in the patient (see arrow) 
coincides with the lactose standard (L) in solvent 1 but is separated from lactose in solvent 2. 
Wenger and colleagues (1986). However, in the latter patient at least, some of the 
clinical manifestations may be attributed to a second disorder, Sanfilippo disease 
type A, which was indicated by a complete deficiency of heparan sulphate sulphami- 
dase. This enzyme deficiency was not present in any of the other patients including 
the two described here. 
In the present family the severe psychomotor retardation, hypotonia nd bone 
anomalies in the proband contrast remarkably with the milder presentation f these 
features in her affected brother and the other reported fl-mannosidosis patients. At 
least one sister (II-6, Figure 1) died with complications a  severe as in the proband, 
but the possible involvement offl-mannosidosis could not be investigated. The causal 
pathogcnesis of the signs and symptoms ofdisease in this family is further complicated 
by mental retardation due to perinatal encephalopathy in the proband's non-identical 
twin sister (II-7), in whom fl-mannosidosis was excluded by a heterozygote level of 
enzyme activity. 
In spite of active searching by several groups, only four families with fi-mannosidosis 
have been found since the discovery of the caprine disease (Jones and Dawson, 1981). 
This suggests that the disorder is quite rare. However, due to the severe neurological 
manifestation f the disease in goats, the disorder may initially have been searched 
for mainly among patients with very early onset of severe neurological complications. 
Also, the specific trisaccharide demonstrated in the urine of affected goats is not 
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present in the human counterpart. Instead, in human patients variable amounts of a 
urinary disaccharide occur (Dorland et al., 1988; Cooper et al., t990), which may be 
obscured by lactose during routine thin layer chromatography. 
The five previously reported patients were all males. Nevertheless, autosomal 
inheritance is suggested by the reduced levels of fl-mannosidase activity in the 
heterozygous parents (e.g. this paper, Table 1 and Dorland et at., 1988) and by 
consanguinity in one couple (Dorland et al., 1988). The present report of the first 
female patient confirms autosomal recessive inheritance. 
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